Publicaciones en colaboración con investigadores/as de Institut d'Investigació Sanitària Pere Virgili (2)

2024

  1. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211

2020

  1. OZF is a Claspin-interacting protein essential to maintain the replication fork progression rate under replication stress

    FASEB Journal, Vol. 34, Núm. 5, pp. 6907-6919